Paul Capital Healthcare does $100m pharma deal
Pharmaceutical companies are looking to alternative forms of financing for research and marketing in the market downturn, according to Paul Capital partner Ken Macleod.
5 January 2013•2 mins read
Pharmaceutical companies are looking to alternative forms of financing for research and marketing in the market downturn, according to Paul Capital partner Ken Macleod.
